ticagrelor

coronary medication

Facts

17 properties
Instance of
type of chemical entity
Subclass of
3-[7-{[2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol[5]
Active ingredient in
Brilique, Possia, Brilinta
Canonical SMILES
CCCSC1=NC2=C(C(=N1)NC3CC3C4=CC(=C(C=C4)F)F)N=NN2C5CC(C(C5O)O)OCCO[3]
Chemical formula
C₂₃H₂₈F₂N₆O₄S[4]
Defined daily dose
0.18 g
Has active ingredient
Ticagrelor
Isomeric SMILES
CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO
Legal status (medicine)
boxed warning
Mass
522.186 Da
Physically interacts with
Purinergic receptor P2Y12[2]
Pregnancy category
US pregnancy category C
Subject has role
xenobiotic-transporting ATPase inhibitor, purinergic P2Y receptor antagonists
World Health Organisation international non-proprietary name
ticagrelor
🏷️ Also known as
en ticagrelor en Ticagrelor en (1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol en (1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-D)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol en AR-C126532XX en AZD 6140 en AZD-6140 en AZD6140 en Brilinta® en Brilique® ar تيكاغريلور cs tikagrelor fa تیکاگرلور fr C23H28F2N6O4S he טיקגרלור ja チカグレロル ko 티카그렐러 pt Brilinta uk тикагрелор zh 替卡格雷
🔖 Identifiers · 39
OpenAlex ID
C2780890252
ATC code
B01AC24
CAS Registry Number
274693-27-5
ChEBI ID
68558
ChEMBL ID
CHEMBL398435
ChemSpider ID
8047109
DSSTOX compound identifier
DTXCID501436166
DSSTox substance ID
DTXSID901009337
DeCS ID
57659
DrugBank ID
DB08816
DrugCentral ID
4184
EC number
619-540-9
Show all 39 identifiers +27
ECHA Substance Infocard ID
100.114.746
Freebase ID
/m/04jcnlb
Guide to Pharmacology Ligand ID
1765
HSDB ID
8306
Human Metabolome Database ID
HMDB0015702
IEDB Epitope ID
244317
KEGG ID
D09017
MeSH descriptor ID
D000077486
MedlinePlus drug identifier
a611050
Microsoft Academic ID (discontinued)
2780890252
NDF-RT ID
N0000182973
PDB ligand ID
TIQ
PDB structure ID
5ALC, 5ALB
PatientsLikeMe treatment ID
ticagrelor
Probes And Drugs ID
PD009197
PubChem CID
9871419
Reaxys registry number
15468079
RxNorm CUI
1116632
SureChEMBL ID
1979652
UMLS CUI
C1999375
UniChem compound ID
18217
WikiProjectMed ID
Ticagrelor

Report an error or request removal Lineage (PROV-JSON)

🔗 Connections
Significant drug interaction 36
← Significant drug interaction 36
Medical condition treated 4
← Drug or therapy used for treatment 4
Has use 1
Legal status (medicine) 1
Press Enter · cited answer in seconds

Summary

ticagrelor is a type of chemical entity[1].

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). ticagrelor. Retrieved November 17, 2026, from https://4ort.xyz/entity/ticagrelor
MLA “ticagrelor.” 4ort.xyz Knowledge Graph, 4ort.xyz, 17 Nov. 2026, https://4ort.xyz/entity/ticagrelor.
BibTeX @misc{4ortxyz_ticagrelor_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{ticagrelor}}, year = {2026}, url = {https://4ort.xyz/entity/ticagrelor}, note = {Accessed: 2026-11-17}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): ticagrelor — https://4ort.xyz/entity/ticagrelor (retrieved 2026-11-17)

Canonical URL: https://4ort.xyz/entity/ticagrelor · Last refreshed: